Search

Jean F. Voltaire

Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )

Most Active Art Unit
2466
Art Unit(s)
2466, 2417
Total Applications
487
Issued Applications
381
Pending Applications
55
Abandoned Applications
68

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5760703 [patent_doc_number] => 20060211648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Naphthalimide compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/356916 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8416 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211648.pdf [firstpage_image] =>[orig_patent_app_number] => 11356916 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/356916
Naphthalimide compositions and uses thereof Feb 15, 2006 Abandoned
Array ( [id] => 7784758 [patent_doc_number] => 20120046314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'NITROXIDES FOR USE IN TREATING OR PREVENTING NEOPLASTIC DISEASE' [patent_app_type] => utility [patent_app_number] => 11/815444 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7763 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046314.pdf [firstpage_image] =>[orig_patent_app_number] => 11815444 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/815444
NITROXIDES FOR USE IN TREATING OR PREVENTING NEOPLASTIC DISEASE Feb 1, 2006 Abandoned
Array ( [id] => 80653 [patent_doc_number] => RE041393 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-06-22 [patent_title] => 'Treatment of refractory tumors using epothilone derivatives' [patent_app_type] => reissue [patent_app_number] => 11/346579 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7173 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041393.pdf [firstpage_image] =>[orig_patent_app_number] => 11346579 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/346579
Treatment of refractory tumors using epothilone derivatives Feb 1, 2006 Issued
Array ( [id] => 5417050 [patent_doc_number] => 20090042937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'NITROXIDES FOR USE IN TREATING OR PREVENTING AMYLOID-RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 11/815436 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5694 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042937.pdf [firstpage_image] =>[orig_patent_app_number] => 11815436 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/815436
NITROXIDES FOR USE IN TREATING OR PREVENTING AMYLOID-RELATED DISEASES Feb 1, 2006 Abandoned
Array ( [id] => 5844740 [patent_doc_number] => 20060122272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Stable gabapentin compositions' [patent_app_type] => utility [patent_app_number] => 11/336846 [patent_app_country] => US [patent_app_date] => 2006-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2500 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122272.pdf [firstpage_image] =>[orig_patent_app_number] => 11336846 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/336846
Stable gabapentin compositions Jan 22, 2006 Abandoned
Array ( [id] => 5625875 [patent_doc_number] => 20060264380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Compounds and Methods for Promoting Angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/306973 [patent_app_country] => US [patent_app_date] => 2006-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9298 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264380.pdf [firstpage_image] =>[orig_patent_app_number] => 11306973 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/306973
Compounds and Methods for Promoting Angiogenesis Jan 17, 2006 Abandoned
Array ( [id] => 5409490 [patent_doc_number] => 20090123388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Prodrugs of Short-Chain Fatty Acids and Treatment Methods' [patent_app_type] => utility [patent_app_number] => 11/813343 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 26741 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123388.pdf [firstpage_image] =>[orig_patent_app_number] => 11813343 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/813343
Prodrugs of Short-Chain Fatty Acids and Treatment Methods Jan 16, 2006 Abandoned
Array ( [id] => 4873796 [patent_doc_number] => 20080200530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Diaryl and Arylheteroaryl Urea Derivatives as Modulators of 5-Ht2a Serotonin Receptor Useful for the Prophylaxis or Treatment of Progressive Multifocal Leukoencephalopathy' [patent_app_type] => utility [patent_app_number] => 11/795489 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 42870 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200530.pdf [firstpage_image] =>[orig_patent_app_number] => 11795489 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/795489
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of 5-Ht2a Serotonin Receptor Useful for the Prophylaxis or Treatment of Progressive Multifocal Leukoencephalopathy Jan 16, 2006 Abandoned
Array ( [id] => 5271020 [patent_doc_number] => 20090074796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Pde5 inhibitor compositions and methods for immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/794855 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19839 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074796.pdf [firstpage_image] =>[orig_patent_app_number] => 11794855 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/794855
Pde5 inhibitor compositions and methods for immunotherapy Jan 8, 2006 Abandoned
Array ( [id] => 5777353 [patent_doc_number] => 20060105993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases' [patent_app_type] => utility [patent_app_number] => 11/325954 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20183 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105993.pdf [firstpage_image] =>[orig_patent_app_number] => 11325954 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/325954
Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases Jan 3, 2006 Abandoned
Array ( [id] => 6223100 [patent_doc_number] => 20100056557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'TREATMENT FOR CUTANEOUS METASTASES' [patent_app_type] => utility [patent_app_number] => 11/722891 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4702 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056557.pdf [firstpage_image] =>[orig_patent_app_number] => 11722891 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/722891
Treatment for cutaneous metastases Dec 29, 2005 Issued
Array ( [id] => 10627585 [patent_doc_number] => 09345725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Pharmaceutical formulations of gallium salts' [patent_app_type] => utility [patent_app_number] => 11/722618 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11607 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11722618 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/722618
Pharmaceutical formulations of gallium salts Dec 28, 2005 Issued
Array ( [id] => 8760172 [patent_doc_number] => 08420693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases' [patent_app_type] => utility [patent_app_number] => 11/794488 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23417 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11794488 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/794488
Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases Dec 21, 2005 Issued
Array ( [id] => 5552852 [patent_doc_number] => 20090286838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'TREATMENT FOR CANCER' [patent_app_type] => utility [patent_app_number] => 11/720884 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8293 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286838.pdf [firstpage_image] =>[orig_patent_app_number] => 11720884 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/720884
TREATMENT FOR CANCER Dec 5, 2005 Abandoned
Array ( [id] => 5815035 [patent_doc_number] => 20060084683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Method for preventing the onset of asthma' [patent_app_type] => utility [patent_app_number] => 11/289434 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3824 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084683.pdf [firstpage_image] =>[orig_patent_app_number] => 11289434 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/289434
Method for preventing the onset of asthma Nov 29, 2005 Abandoned
Array ( [id] => 5546725 [patent_doc_number] => 20090156602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 11/719838 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17716 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156602.pdf [firstpage_image] =>[orig_patent_app_number] => 11719838 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/719838
Organic Compounds Nov 21, 2005 Abandoned
Array ( [id] => 5721318 [patent_doc_number] => 20060074094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia' [patent_app_type] => utility [patent_app_number] => 11/285664 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3620 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074094.pdf [firstpage_image] =>[orig_patent_app_number] => 11285664 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/285664
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia Nov 21, 2005 Issued
Array ( [id] => 5392260 [patent_doc_number] => 20090209573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS' [patent_app_type] => utility [patent_app_number] => 11/718226 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6554 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209573.pdf [firstpage_image] =>[orig_patent_app_number] => 11718226 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/718226
COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS Oct 27, 2005 Abandoned
Array ( [id] => 9703910 [patent_doc_number] => 08828972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Formulations containing alkylphosphocholines using novel negative charge carriers' [patent_app_type] => utility [patent_app_number] => 11/577518 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9907 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11577518 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/577518
Formulations containing alkylphosphocholines using novel negative charge carriers Oct 18, 2005 Issued
Array ( [id] => 5570321 [patent_doc_number] => 20090253699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Compounds for Nonsense Suppression, and Methods for Their Use' [patent_app_type] => utility [patent_app_number] => 11/577191 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 48862 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253699.pdf [firstpage_image] =>[orig_patent_app_number] => 11577191 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/577191
1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease Oct 12, 2005 Issued
Menu